Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma (original) (raw)

• Kay, A. B. Allergy and allergic diseases. First of two parts. N. Engl. J. Med. 344, 30–37 (2001).
  Article CAS PubMed Google Scholar
• Holgate, S. T. & Broide, D. New targets for allergic rhinitis — a disease of civilization. Nature Rev. Drug Discov. 2, 902–914 (2003).
  Google Scholar
• The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351, 1225–1232 (1998).
• Burney, P. et al. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J. Allergy Clin. Immunol. 99, 314–322 (1997).
  CAS PubMed Google Scholar
• Robinson, D. S. TH2 cytokines in allergic disease. Br. Med. Bull. 56, 956–968 (2000).
  CAS PubMed Google Scholar
• Cookson, W. & Moffatt, M. Making sense of asthma genes. N. Engl. J. Med. 351, 1794–1796 (2004).
  CAS PubMed Google Scholar
• Wills-Karp, M., Santeliz, J. & Karp, C. L. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nature Rev. Immunol. 1, 69–75 (2001).
  CAS Google Scholar
• Mosmann, T. R. & Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
  CAS PubMed Google Scholar
• Romagnani, S. Regulation of the development of type 2 T-helper cells in allergy. Curr. Opin. Immunol. 6, 838–846 (1994).
  CAS PubMed Google Scholar
• Robinson, D. S. et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326, 298–304 (1992). This is an important early study that showed the presence of T H 2-cytokine-mRNA-positive T cells in the lungs of patients with allergic asthma.
  CAS PubMed Google Scholar
• Bentley, A. M. et al. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8, 35–42 (1993).
  CAS PubMed Google Scholar
• Lloyd, C. M., Gonzalo, J. A., Coyle, A. J. & Gutierrez-Ramos, J. C. Mouse models of allergic airway disease. Adv. Immunol. 77, 263–295 (2001).
  CAS PubMed Google Scholar
• Barnes, P. J. Current therapies for asthma. Promise and limitations. Chest 111, 17S–26S (1997).
  CAS PubMed Google Scholar
• Maloy, K. J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nature Immunol. 2, 816–822 (2001).
  CAS Google Scholar
• Sakaguchi, S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531–562 (2004).
  CAS PubMed Google Scholar
• O'Garra, A. & Vieira, P. Regulatory T cells and mechanisms of immune system control. Nature Med. 10, 801–805 (2004).
  CAS PubMed Google Scholar
• Shevach, E. CD4+CD25+ suppressor T cells: more questions than answers. Nature Rev. Immunol. 2, 389–400 (2002). References 14–17 are key reviews that describe naturally occurring and antigen-driven regulatory T cells, and they refer to the important original papers in this field.
  CAS Google Scholar
• Annacker, O. et al. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008–3018 (2001).
  CAS PubMed Google Scholar
• Maloy, K. J. et al. CD4+CD25+ TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111–119 (2003).
  CAS PubMed PubMed Central Google Scholar
• Jordan, M. S. et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nature Immunol. 2, 301–306 (2001).
  CAS Google Scholar
• Apostolou, I. & Von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401–1408 (2004).
  CAS PubMed PubMed Central Google Scholar
• Baecher-Allan, C., Viglietta, V. & Hafler, D. A. Inhibition of human CD4+CD25+high regulatory T cell function. J. Immunol. 169, 6210–6217 (2002).
  CAS PubMed Google Scholar
• Sakaguchi, S. et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 182, 18–32 (2001).
  CAS PubMed Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135–142 (2002).
  CAS Google Scholar
• McHugh, R. S. et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311–323 (2002).
  CAS PubMed Google Scholar
• Green, E. A., Gorelik, L., McGregor, C. M., Tran, E. H. & Flavell, R. A. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β–TGF-β receptor interactions in type 1 diabetes. Proc. Natl Acad. Sci. USA 100, 10878–10883 (2003).
  CAS PubMed PubMed Central Google Scholar
• Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995–1004 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. & Sacks, D. L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507 (2002).
  CAS PubMed Google Scholar
• Suri-Payer, E. & Cantor, H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+CD25+ T cells. J. Autoimmun. 16, 115–123 (2001).
  CAS PubMed Google Scholar
• Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).
  CAS PubMed Google Scholar
• Khattri, R., Cox, T., Yasayko, S. A. & Ramsdell, F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nature Immunol. 4, 337–342 (2003).
  CAS Google Scholar
• Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330–336 (2003). References 32–34 were the first to describe the transcription factor FOXP3 and its role in the development of naturally occurring T Reg cells.
  CAS Google Scholar
• Ramsdell, F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19, 165–168 (2003).
  CAS PubMed Google Scholar
• Yagi, H. et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16, 1643–1656 (2004).
  CAS PubMed Google Scholar
• Chen, W. et al. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003).
  CAS PubMed PubMed Central Google Scholar
• Walker, M. R. et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25− T cells. J. Clin. Invest. 112, 1437–1443 (2003).
  CAS PubMed Google Scholar
• Powrie, F. et al. Inhibition of TH1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1, 553–562 (1994).
  CAS PubMed Google Scholar
• Liu, H., Hu, B., Xu, D. & Liew, F. Y. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171, 5012–5017 (2003).
  CAS PubMed Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  CAS PubMed Google Scholar
• Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789–3796 (2001).
  CAS PubMed Google Scholar
• Kingsley, C. I., Karim, M., Bushell, A. R. & Wood, K. J. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168, 1080–1086 (2002).
  CAS PubMed Google Scholar
• Shimizu, J., Yamazaki, S. & Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211–5218 (1999).
  CAS PubMed Google Scholar
• Golgher, D., Jones, E., Powrie, F., Elliott, T. & Gallimore, A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32, 3267–3275 (2002).
  CAS PubMed Google Scholar
• Xu, D. et al. CD4+CD25+ regulatory T cells suppress differentiation and functions of TH1 and TH2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170, 394–399 (2003).
  CAS PubMed Google Scholar
• Stassen, M. et al. Differential regulatory capacity of CD25+ T regulatory cells and preactivated CD25+ T regulatory cells on development, functional activation, and proliferation of TH2 cells. J. Immunol. 173, 267–274 (2004).
  CAS PubMed Google Scholar
• Kinter, A. L. et al. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331–343 (2004).
  CAS PubMed PubMed Central Google Scholar
• Aandahl, E. M., Michaelsson, J., Moretto, W. J., Hecht, F. M. & Nixon, D. F. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78, 2454–2459 (2004).
  CAS PubMed PubMed Central Google Scholar
• Oswald-Richter, K. et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2, E198 (2004).
  PubMed PubMed Central Google Scholar
• Hadeiba, H. & Locksley, R. M. Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 170, 5502–5510 (2003).
  CAS PubMed Google Scholar
• Bellinghausen, I., Klostermann, B., Knop, J. & Saloga, J. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J. Allergy Clin. Immunol. 111, 862–868 (2003).
  CAS PubMed Google Scholar
• Ling, E. M. et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363, 608–615 (2004). References 52 and 53 were the first to indicate that there might be a defect in the function of naturally occurring T Reg cells in patients with active allergic disease. Reference 53 also indicates that active suppression of allergen-specific T H 2 responses occurs in healthy, non-atopic individuals.
  CAS PubMed Google Scholar
• O'Garra, A., Vieira, P. L., Vieira, P. & Goldfeld, A. E. IL-10-producing and naturally occurring CD4+ TRegs: limiting collateral damage. J. Clin. Invest. 114, 1372–1378 (2004).
  CAS PubMed PubMed Central Google Scholar
• Read, S. et al. CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28, 3435–3447 (1998).
  CAS PubMed Google Scholar
• Asseman, C., Read, S. & Powrie, F. Colitogenic TH1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J. Immunol. 171, 971–978 (2003).
  CAS PubMed Google Scholar
• Sundstedt, A. et al. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J. Immunol. 158, 180–186 (1997).
  CAS PubMed Google Scholar
• Sundstedt, A., O'Neill, E. J., Nicolson, K. S. & Wraith, D. C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170, 1240–1248 (2003).
  CAS PubMed Google Scholar
• Groux, H. et al. Generation of a novel regulatory CD4+ T-cell population, which inhibits antigen-specific T-cell responses. Nature 389, 737–742 (1997).
  CAS PubMed Google Scholar
• Levings, M. K. et al. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530–5539 (2001).
  CAS PubMed Google Scholar
• Buer, J. et al. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187, 177–183 (1998).
  CAS PubMed PubMed Central Google Scholar
• Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (TH1)- and TH2-inducing cytokines. J. Exp. Med. 195, 603–616 (2002). This study describes the in vitro generation, using immunosuppressive drugs, of homogeneous populations of IL-10-secreting regulatory T cells that do not produce T H 1 or T H 2 cytokines, which has implications for immunotherapy.
  CAS PubMed PubMed Central Google Scholar
• Pontoux, C., Banz, A. & Papiernik, M. Natural CD4 CD25+ regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10. Int. Immunol. 14, 233–239 (2002).
  CAS PubMed Google Scholar
• Weiner, H. L. Induction and mechanism of action of transforming growth factor-β-secreting TH3 regulatory cells. Immunol. Rev. 182, 207–214 (2001).
  CAS PubMed Google Scholar
• Kemper, C. et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421, 388–392 (2003).
  CAS PubMed Google Scholar
• Bacchetta, R. et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179, 493–502 (1994). This is an important early study that describes that high endogenous IL-10 production is a general phenomenon in patients with SCID in whom allogeneic haematopoietic stem-cell transplantation results in immunological reconstitution and induction of tolerance. This has been a seminal paper in the current resurgence of interest in the therapeutic applications of regulatory T cells.
  CAS PubMed Google Scholar
• Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. & Enk, A. H. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192, 1213–1222 (2000).
  CAS PubMed PubMed Central Google Scholar
• Richards, D. F., Fernandez, M., Caulfield, J. & Hawrylowicz, C. M. Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30, 2344–2354 (2000).
  CAS PubMed Google Scholar
• Miller, C., Ragheb, J. A. & Schwartz, R. H. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J. Exp. Med. 190, 53–64 (1999).
  CAS PubMed PubMed Central Google Scholar
• Vieira, P. L. et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 172, 5986–5993 (2004). This study shows that IL-10-secreting regulatory T cells, unlike naturally occurring T Reg cells, do not express FOXP3, but both populations have a comparable ability to inhibit the proliferation of naive T cells.
  CAS PubMed Google Scholar
• Akdis, C. A., Blesken, T., Akdis, M., Wuthrich, B. & Blaser, K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102, 98–106 (1998). This is a comprehensive early study that shows the association of IL-10 production with tolerance to allergen. The authors provide evidence for IL-10 production in response to allergen following successful allergen immunotherapy of bee-keepers who had become tolerant following repeated stings and of non-atopic individuals.
  CAS PubMed PubMed Central Google Scholar
• Akbari, O., DeKruyff, R. H. & Umetsu, D. T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2, 725–731 (2001).
  CAS Google Scholar
• Akbari, O. et al. Antigen-specific regulatory T cells develop via the ICOS–ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nature Med. 8, 1024–1032 (2002). References 72 and 73 are studies from the same research group that identify pulmonary DCs and T cells as important sources of IL-10 in the lungs and identify the role of IL-10 in the induction of respiratory tolerance.
  CAS PubMed Google Scholar
• Boussiotis, V. A. et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105, 1317–1325 (2000).
  CAS PubMed PubMed Central Google Scholar
• Gerosa, F. et al. CD4+ T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92, 224–234 (1999).
  CAS PubMed Google Scholar
• Trinchieri, G. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. J. Exp. Med. 194, F53–F57 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kullberg, M. C. et al. Bacteria-triggered CD4+ T regulatory cells suppress _Helicobacter hepaticus_-induced colitis. J. Exp. Med. 196, 505–515 (2002).
  CAS PubMed PubMed Central Google Scholar
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  CAS PubMed Google Scholar
• Akdis, M. et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 199, 1567–1575 (2004). This is a recent study showing that IL-10-secreting regulatory T cells are the dominant cell subset that is specific for common environmental allergens in healthy individuals, whereas there is a high frequency of allergen-specific IL-4-secreting T cells in allergic individuals.
  CAS PubMed PubMed Central Google Scholar
• Hawrylowicz, C. Correction of the defect in glucocorticoid-induced IL-10 synthesis in T cells from glucocorticoid resistant asthmatic patients. J. Allergy Clin. Immunol. 113 (Suppl.), A735 (2004). This study shows that vitamin D 3 and IL-10 can restore the reactivity of T cells from steroid-resistant patients to glucocorticoids and thereby induce IL-10 synthesis.
  Google Scholar
• Francis, J. N., Till, S. J. & Durham, S. R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J. Allergy Clin. Immunol. 111, 1255–1261 (2003).
  CAS PubMed Google Scholar
• Robinson, D. S., Larche, M. & Durham, S. R. TRegs and allergic disease. J. Clin. Invest. 114, 1389–1397 (2004).
  CAS PubMed PubMed Central Google Scholar
• Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20–21 (2001).
  CAS PubMed Google Scholar
• Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nature Genet. 27, 18–20 (2001).
  CAS PubMed Google Scholar
• Chatila, T. A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity–allergic disregulation syndrome. J. Clin. Invest. 106, R75–R81 (2000). References 83–85 show that mutations in the human FOXP3 gene are associated with immune dysregulation and disease.
  CAS PubMed PubMed Central Google Scholar
• Grindebacke, H. et al. Defective suppression of TH2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin. Exp. Allergy 34, 1364–1372 (2004).
  CAS PubMed Google Scholar
• Suto, A. et al. Role of CD4+ CD25+ regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am. J. Respir. Crit. Care Med. 164, 680–687 (2001).
  CAS PubMed Google Scholar
• Jaffar, Z., Sivakuru, T. & Roberts, K. CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the TH2 cell phenotype. J. Immunol. 172, 3842–3849 (2004).
  CAS PubMed Google Scholar
• Curotto de Lafaille, M. A. et al. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J. Exp. Med. 194, 1349–1359 (2001).
  CAS PubMed Google Scholar
• Ostroukhova, M. et al. Tolerance induced by inhaled antigen involves CD4+ T cells expressing membrane-bound TGF-β and FOXP3. J. Clin. Invest. 114, 28–38 (2004).
  CAS PubMed PubMed Central Google Scholar
• Fiorentino, D. F., Bond, M. W. & Mosmann, T. R. Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J. Exp. Med. 170, 2081–2095 (1989).
  CAS PubMed Google Scholar
• Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001). This is a comprehensive review of the biology of IL-10.
  CAS PubMed Google Scholar
• Fiorentino, D. F. et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by TH1 cells. J. Immunol. 146, 3444–3451 (1991).
  CAS PubMed Google Scholar
• de Waal Malefyt, R. et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915–924 (1991).
  CAS PubMed Google Scholar
• Gazzinelli, R. T., Oswald, I. P., James, S. L. & Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148, 1792–1796 (1992).
  CAS PubMed Google Scholar
• Buelens, C. et al. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur. J. Immunol. 27, 756–762 (1997).
  CAS PubMed Google Scholar
• Gerber, J. S. & Mosser, D. M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166, 6861–6868 (2001).
  CAS PubMed Google Scholar
• de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. & de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209–1220 (1991).
  CAS PubMed Google Scholar
• Edwards, A. D. et al. Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J. Immunol. 169, 3652–3660 (2002).
  CAS PubMed Google Scholar
• McGuirk, P., McCann, C. & Mills, K. H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195, 221–231 (2002).
  CAS PubMed PubMed Central Google Scholar
• Grunig, G. et al. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185, 1089–1099 (1997). This was the first report to describe that IL-10 inhibits allergic, as well as T H 1, responses in vivo.
  CAS PubMed PubMed Central Google Scholar
• Asadullah, K., Sterry, W. & Volk, H. D. Interleukin-10 therapy — review of a new approach. Pharmacol. Rev. 55, 241–269 (2003). This is a comprehensive review of clinical studies involving IL-10.
  CAS PubMed Google Scholar
• Arock, M., Zuany-Amorim, C., Singer, M., Benhamou, M. & Pretolani, M. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26, 166–70 (1996).
  CAS PubMed Google Scholar
• Royer, B. et al. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31, 694–704 (2001).
  CAS PubMed Google Scholar
• Takanaski, S. et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180, 711–715 (1994). References 103–105 are early studies showing that IL-10 inhibits T H 2-response-regulated effector mechanisms associated with allergy, as well as T H 1 responses.
  CAS PubMed Google Scholar
• Nouri-Aria, K. T. et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J. Immunol. 172, 3252–3259 (2004).
  CAS PubMed Google Scholar
• Jeannin, P., Lecoanet, S., Delneste, Y., Gauchat, J. F. & Bonnefoy, J. Y. IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. 160, 3555–3561 (1998).
  CAS PubMed Google Scholar
• Borish, L. et al. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97, 1288–1296 (1996).
  CAS PubMed Google Scholar
• Lim, S., Crawley, E., Woo, P. & Barnes, P. J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 352, 113 (1998).
  CAS PubMed Google Scholar
• Heaton, T. et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 365, 142–149 (2005). References 108–110 provide evidence for an inverse correlation of IL-10 levels with disease severity.
  CAS PubMed Google Scholar
• Stampfli, M. R. et al. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice. Am. J. Respir. Cell Mol. Biol. 21, 586–596 (1999).
  CAS PubMed Google Scholar
• Oh, J. W. et al. CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. J. Allergy Clin. Immunol. 110, 460–468 (2002).
  CAS PubMed Google Scholar
• Fuchs, A. C. et al. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J. Clin. Immunol. 16, 291–303 (1996).
  CAS PubMed Google Scholar
• Norman, P. S. Immunotherapy: past and present. J. Allergy Clin. Immunol. 102, 1–10 (1998).
  CAS PubMed Google Scholar
• Bousquet, J. et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 81, 401–405 (1998).
  CAS PubMed Google Scholar
• Norman, P. S. Immunotherapy: 1999–2004. J. Allergy Clin. Immunol. 113, 1013–1023 (2004).
  CAS PubMed Google Scholar
• Wilson, D. R., Torres, L. I. & Durham, S. R. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst. Rev. 2, CD002893 (2003).
  Google Scholar
• Moller, C. et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J. Allergy Clin. Immunol. 109, 251–256 (2002).
  PubMed Google Scholar
• Pajno, G. B., Barberio, G., De Luca, F., Morabito, L. & Parmiani, S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin. Exp. Allergy 31, 1392–1397 (2001).
  CAS PubMed Google Scholar
• Casale, T. B. Status of immunotherapy: current and future. J. Allergy Clin. Immunol. 113, 1036–1039 (2004).
  PubMed Google Scholar
• Jutel, M. et al. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154, 4187–4194 (1995). This was the first study to show that allergen immunotherapy is associated with a switch from a T H 2 phenotype towards a T H 1 phenotype.
  CAS PubMed Google Scholar
• Ebner, C. et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen. Clin. Exp. Allergy 27, 1007–1015 (1997).
  CAS PubMed Google Scholar
• Wachholz, P. A. et al. Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral TH1:TH2 cytokine ratios. Immunology 105, 56–62 (2002).
  CAS PubMed PubMed Central Google Scholar
• Soderlund, A. et al. Allergen induced cytokine profiles in type I allergic individuals before and after immunotherapy. Immunol. Lett. 57, 177–181 (1997).
  CAS PubMed Google Scholar
• van Bever, H. P., Vereecke, I. F., Bridts, C. H., De Clerck, L. S. & Stevens, W. J. Comparison between the in vitro cytokine production of mononuclear cells of young asthmatics with and without immunotherapy (IT). Clin. Exp. Allergy 28, 943–949 (1998).
  CAS PubMed Google Scholar
• Klimek, L. et al. Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis. Clin. Exp. Allergy 29, 1326–1335 (1999).
  CAS PubMed Google Scholar
• Cook, D. N., Pisetsky, D. S. & Schwartz, D. A. Toll-like receptors in the pathogenesis of human disease. Nature Immunol. 5, 975–979 (2004).
  CAS Google Scholar
• Bellinghausen, I. et al. Insect venom immunotherapy induces interleukin-10 production and a TH2-to-TH1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27, 1131–1139 (1997).
  CAS PubMed Google Scholar
• Till, S. J., Francis, J. N., Nouri-Aria, K. & Durham, S. R. Mechanisms of immunotherapy. J. Allergy Clin. Immunol. 113, 1025–1034 (2004).
  CAS PubMed Google Scholar
• Jutel, M. et al. IL-10 and TGF-β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. 33, 1205–1214 (2003).
  CAS PubMed Google Scholar
• Faith, A. et al. Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy. Clin. Exp. Allergy 33, 1209–1215 (2003).
  CAS PubMed Google Scholar
• Oldfield, W. L., Larche, M. & Kay, A. B. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360, 47–53 (2002).
  CAS PubMed Google Scholar
• Djurup, R. & Malling, H. J. High IgG4 antibody level is associated with failure of immunotherapy with inhalant allergens. Clin. Allergy 17, 459–468 (1987).
  CAS PubMed Google Scholar
• Ewan, P. W., Deighton, J., Wilson, A. B. & Lachmann, P. J. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin. Exp. Allergy 23, 647–660 (1993).
  CAS PubMed Google Scholar
• Punnonen, J., Aversa, G. G., Vandekerckhove, B., Roncarolo, M. G. & de Vries, J. E. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. J. Immunol. 148, 3398–3404 (1992).
  CAS PubMed Google Scholar
• Akdis, C. A. et al. Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 99, 345–353 (1997). This is an early report of differential regulation of IgE and IgG4, which led to a series of publications (many of which are highlighted here) proposing that this is an important mechanism associated with successful allergen immunotherapy.
  CAS PubMed Google Scholar
• van Neerven, R. J. et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163, 2944–2952 (1999).
  CAS PubMed Google Scholar
• Wachholz, P. A. & Durham, S. R. Induction of 'blocking' IgG antibodies during immunotherapy. Clin. Exp. Allergy 33, 1171–1174 (2003).
  CAS PubMed Google Scholar
• Wachholz, P. A., Soni, N. K., Till, S. J. & Durham, S. R. Inhibition of allergen–IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J. Allergy Clin. Immunol. 112, 915–922 (2003).
  CAS PubMed Google Scholar
• Valenta, R. & Kraft, D. From allergen structure to new forms of allergen-specific immunotherapy. Curr. Opin. Immunol. 14, 718–727 (2002).
  CAS PubMed Google Scholar
• Kuehr, J. et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J. Allergy Clin. Immunol. 109, 274–280 (2002).
  CAS PubMed Google Scholar
• Rolinck-Werninghaus, C. et al. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy 59, 973–979 (2004).
  CAS PubMed Google Scholar
• Maurer, D. et al. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J. Immunol. 154, 6285–6290 (1995).
  CAS PubMed Google Scholar
• Novak, N., Bieber, T. & Katoh, N. Engagement of FcεRI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J. Immunol. 167, 797–804 (2001). References 143 and 144 provide evidence that crosslinking of IgE regulates APC function.
  CAS PubMed Google Scholar
• Larche, M. & Kay, A. B. Peptide therapy and asthma. Am. J. Respir. Crit. Care Med. 169, 1331–1332 (2004).
  PubMed Google Scholar
• Norman, P. S. et al. Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care Med. 154, 1623–1628 (1996).
  CAS PubMed Google Scholar
• Muller, U. et al. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. 101, 747–754 (1998).
  CAS PubMed Google Scholar
• Haselden, B. M., Kay, A. B. & Larche, M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J. Exp. Med. 189, 1885–1894 (1999). References 147 and 148 are independent studies that were the first to describe the successful use of peptides derived from allergen for use in allergen immunotherapy.
  CAS PubMed PubMed Central Google Scholar
• Oldfield, W. L., Kay, A. B. & Larche, M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J. Immunol. 167, 1734–1739 (2001).
  CAS PubMed Google Scholar
• Ali, F. R., Oldfield, W. L., Higashi, N., Larche, M. & Kay, A. B. Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am. J. Respir. Crit. Care Med. 169, 20–26 (2004).
  PubMed Google Scholar
• Fellrath, J. M. et al. Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a Phase I trial. J. Allergy Clin. Immunol. 111, 854–861 (2003).
  CAS PubMed Google Scholar
• Smith, T. R., Alexander, C., Kay, A. B., Larche, M. & Robinson, D. S. Cat allergen peptide immunotherapy reduces CD4 T cell responses to cat allergen but does not alter suppression by CD4 CD25 T cells: a double-blind placebo-controlled study. Allergy 59, 1097–1101 (2004).
  CAS PubMed Google Scholar
• Hoyne, G. F., O'Hehir, R. E., Wraith, D. C., Thomas, W. R. & Lamb, J. R. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178, 1783–1788 (1993).
  CAS PubMed Google Scholar
• Ling, E. M. et al. Allergen immunotherapy increases suppressive activity by CD4+CD25−, IL-10 producing T cells, but does not affect suppression by CD4+CD25+ T cells. J. Allergy Clin. Immunol. 113 (Suppl.), A333 (2004).
  Google Scholar
• Krieg, A. M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709–760 (2002).
  CAS PubMed Google Scholar
• Akira, S. & Takeda, K. Toll-like receptor signalling. Nature Rev. Immunol. 4, 499–511 (2004).
  CAS Google Scholar
• Duramad, O. et al. IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 102, 4487–4492 (2003).
  CAS PubMed Google Scholar
• Friedberg, J. W. et al. Combination immunotherapy with a CpG oligonucleotide (1018 ISS) and rituximab in patients with non-Hodgkin lymphoma: increased interferon-α/β-inducible gene expression, without significant toxicity. Blood 105, 489–495 (2004).
  PubMed Google Scholar
• Tighe, H. et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity. J. Allergy Clin. Immunol. 106, 124–134 (2000).
  CAS PubMed Google Scholar
• Marshall, J. D. et al. Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy. J. Allergy Clin. Immunol. 108, 191–197 (2001).
  CAS PubMed Google Scholar
• Tulic, M. K. et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J. Allergy Clin. Immunol. 113, 235–241 (2004).
  CAS PubMed Google Scholar
• Simons, F. E., Shikishima, Y., Van Nest, G., Eiden, J. J. & HayGlass, K. T. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy Clin. Immunol. 113, 1144–1151 (2004). References 161 and 162 describe a novel clinical approach (with encouraging early results) that seeks to improve the efficacy of allergen immunotherapy by conjugating allergen with immunostimulatory DNA motifs.
  CAS PubMed Google Scholar
• Durez, P. et al. Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-α and upregulation of IL-10 release. Int. J. Immunopharmacol. 21, 581–587 (1999).
  CAS PubMed Google Scholar
• Durez, P. et al. In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J. Exp. Med. 177, 551–555 (1993).
  CAS PubMed Google Scholar
• Bergmann, M. & Sautner, T. Immunomodulatory effects of vasoactive catecholamines. Wien. Klin. Wochenschr. 114, 752–761 (2002).
  CAS PubMed Google Scholar
• Hasko, G., Deitch, E. A., Szabo, C., Nemeth, Z. H. & Vizi, E. S. Adenosine: a potential mediator of immunosuppression in multiple organ failure. Curr. Opin. Pharmacol. 2, 440–444 (2002).
  CAS PubMed Google Scholar
• Corral, L. G. et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α. J. Immunol. 163, 380–386 (1999).
  CAS PubMed Google Scholar
• Sawicka, E. et al. Inhibition of TH1- and TH2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J. Immunol. 171, 6206–6214 (2003).
  CAS PubMed Google Scholar
• Schafer, P. H. et al. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs. J. Pharmacol. Exp. Ther. 305, 1222–1232 (2003).
  CAS PubMed Google Scholar
• Casnici, C., Lattuada, D., Franco, P., Cattaneo, L. & Marelli, O. Regulation of human peripheral blood lymphocytes IL-10 by SMS 201-995. J. Neuroimmunol. 149, 210–216 (2004).
  CAS PubMed Google Scholar
• Wan, S., LeClerc, J. L. & Vincent, J. L. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann. Thorac. Surg. 63, 269–276 (1997).
  CAS PubMed Google Scholar
• John, M. et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte–macrophage colony-stimulating factor and interferon-γ release from alveolar macrophages in asthma. Am. J. Respir. Crit. Care Med. 157, 256–262 (1998).
  CAS PubMed Google Scholar
• Hawrylowicz, C., Richards, D., Loke, T. K., Corrigan, C. & Lee, T. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. J. Allergy Clin. Immunol. 109, 369–370 (2002). This paper provides evidence that correlates failure to respond clinically to glucocorticoid treatment with a defect in T-cell responsiveness to glucocorticoids that results in reduced IL-10 expression in vitro.
  CAS PubMed Google Scholar
• Peek, E. et al. Combining long-acting β2-agonists and glucocorticoids induces greater inhibition of allergen-specific TH2 cytokine responses and enhances IL-10 responses. J. Allergy Clin. Immunol. 113 (Suppl.), A753 (2004).
  Google Scholar
• Canning, M. O., Grotenhuis, K., de Wit, H. J. & Drexhage, H. A. Opposing effects of dehydroepiandrosterone and dexamethasone on the generation of monocyte-derived dendritic cells. Eur. J. Endocrinol. 143, 687–695 (2000).
  CAS PubMed Google Scholar
• Dong, X., Bachman, L. A., Kumar, R. & Griffin, M. D. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl. Immunol. 11, 323–333 (2003).
  CAS PubMed Google Scholar
• McGuirk, P. & Mills, K. H. Pathogen-specific regulatory T cells provoke a shift in the TH1/TH2 paradigm in immunity to infectious diseases. Trends Immunol. 23, 450–455 (2002).
  CAS PubMed Google Scholar
• Zuany-Amorim, C. et al. Suppression of airway eosinophilia by killed _Mycobacterium vaccae_-induced allergen-specific regulatory T-cells. Nature Med. 8, 625–629 (2002).
  CAS PubMed Google Scholar
• Ulisse, S. et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96, 2691–2699 (2001).
  CAS PubMed Google Scholar
• Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. & Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869–1871 (2003).
  PubMed Google Scholar
• Kalliomaki, M. & Isolauri, E. Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol. 3, 15–20 (2003).
  CAS PubMed Google Scholar
• Cottrez, F., Hurst, S. D., Coffman, R. L. & Groux, H. T regulatory cells 1 inhibit a TH2-specific response in vivo. J. Immunol. 165, 4848–4853 (2000).
  CAS PubMed Google Scholar
• Hansen, G. et al. CD4+ T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105, 61–70 (2000).
  CAS PubMed PubMed Central Google Scholar
• Arkwright, P. D. & David, T. J. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br. J. Dermatol. 149, 1029–1034 (2003).
  CAS PubMed Google Scholar
• Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46–53 (2002).
  CAS Google Scholar
• Tiemessen, M. M. et al. CD4 CD25 regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy. J. Allergy Clin. Immunol. 110, 934–936 (2002).
  PubMed Google Scholar
• Idzko, M. et al. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J. Allergy Clin. Immunol. 109, 839–846 (2002).
  CAS PubMed Google Scholar
• Kunzmann, S. et al. Histamine enhances TGF-β1-mediated suppression of TH2 responses. FASEB J. 17, 1089–1095 (2003).
  CAS PubMed Google Scholar